Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations

Brain

Volumn 130, Issue 7, 2007, Pages 1767-1776

  Ringman, John M ^a   O'Neill, Joseph ^b   Geschwind, Daniel ^a   Medina, Luis ^a   Apostolova, Liana G ^a   Rodriguez, Yaneth ^c   Schaffer, Barbara ^a   Varpetian, Arousiak ^d   Tseng, Benjamin ^b   Ortiz, Freddy ^a,e,f   Fitten, Jaime ^a,e,f   Cummings, Jeffrey L ^a,b   Bartzokis, George ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^d RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^e OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^f VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Amyloid precursor protein; Biomarker; Diffusion tensor imaging; Familial Alzheimer's disease; Fornix; Fractional anisotropy; Presenilin 1; Presymptomatic; White matter

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ANISOTROPY; ARTICLE; BRAIN FORNIX; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE MARKER; FAMILIAL DISEASE; FEMALE; FRONTAL LOBE; GENE MUTATION; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; ORBITAL CORTEX; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; WHITE MATTER; AGE; BRAIN; BRAIN MAPPING; DIFFUSION WEIGHTED IMAGING; GENETICS; IMAGE PROCESSING; METHODOLOGY; MUTATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

ADULT; AGE FACTORS; ALZHEIMER DISEASE; ANISOTROPY; BRAIN; BRAIN MAPPING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FORNIX (BRAIN); HETEROZYGOTE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MUTATION; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 34447618051     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm102     Document Type: Article

References (38)

1. Assini A, Terreni L, Borghi R, Giliberto L, Piccini A, Loqui D, et al. Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation. Neurology 2003; 60: 150.
2. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004; 25: 5-18 author reply 49-62.
3. Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 2001; 58: 461-5.
4. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 2003; 60: 393-8.
5. Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 2006; 63: 63-72.
6. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 2004; 25: 843-51.
7. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259-67.
8. Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003; 50: 1077-88.
9. Bozoki A, Delano M, Huang J, Potchen M. Diffusion tensor imaging of the fornix in Alzheimer's disease. Neurology 2004; 62: A126.
10. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002; 72: 742-6.
11. Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol (Berl) 1996; 92: 197-201.
12. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001; 57: 1669-74.
13. Chia LS, Thompson JE, Moscarello MA. X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. Biochim Biophys Acta 1984; 775: 308-12.
14. Cochran EJ, Murrell JR, Fox J, Ringman J, Ghetti B. A novel mutation in the Presenilin-1 gene (A431E) associated with early-onset Alzheimer's disease. J Neuropathol Exp Neurol 2001; 60: 544.
15. Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 1988; 111 (Pt 6): 1425-39.
16. Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques PK, Collinge J, et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 1997; 120: 491-501.
17. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996; 16: 4491-500.
18. Handler M, Yang X, Shen J. Presenilin-1 regulates neuronal differentiation during neurogenesis. Development 2000; 127: 2593-606.
19. Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 2000; 48: 806-8.
20. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143-56.
21. Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Wiest R, et al. Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage 2006; 30: 713-20.
22. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2005; 64: 902-4.
23. Medina D, DeToledo-Morrell L, Urresta F, Gabrieli JD, Moseley M, Fleischman D, et al. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol Aging 2006; 27: 663-72.
24. Mullan M, Tsuji S, Miki T, Katsuya T, Naruse S, Kaneko K, et al. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val - >Ile mutation in the amyloid precursor protein gene. Neurobiol Aging 1993; 14: 407-19.
25. Murrell J, Ghetti B, Cochran E, Macias-Islas MA, Medina L, Varpetian A, et al. The A431E mutation in PSEN1 causing Familial Alzheimer's Disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics 2006; 7: 277-9.
26. Pak K, Chan SL, Mattson MP. Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice. Neuromolecular Med 2003; 3: 53-64.
27. Pantel J, O'Leary DS, Cretsinger K, Bockholt HJ, Keefe H, Magnotta VA, et al. A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy. Hippocampus 2000; 10: 752-8.
28. Papanikolaou N, Papadaki E, Karampekios S, Spilioti M, Maris T, Prassopoulos P, et al. T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio. Eur Radiol 2004; 14: 115-22.
29. Persson J, Lind J, Larsson A, Ingvar M, Cruts M, Van Broeckhoven C, et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology 2006; 66: 1029-33.
30. Rose SE, McMahon KL, Janke AL, O'Dowd B, de Zubicaray G, Strudwick MW, et al. Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry 2006; 77: 1122-8.
31. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143-55.
32. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23 (Suppl 1): S208-19.
33. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-89.
34. Takao M, Ghetti B, Murrell JR, Unverzagt FW, Giaccone G, Tagliavini F, et al. Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 2001; 60: 1137-52.
35. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998; 279: 751-5.
36. Terry RD, Gonatas NK, Weiss M. Ultrastructural studies in Alzheimer's Presenile dementia. Am J Pathol 1964; 44: 269-97.
37. Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol (Berl) 2006; 111: 312-9.
38. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001; 20: 45-57.